Dr. Michael Hermann Eberlein, MD

Dr. Eberlein practices at University Health Services - Madison (Highland Ave) in Madison, Wisconsin.

Dr. Eberlein's NPI, 1568482362, was assigned on July 21, 2006. Dr. Eberlein holds Wisconsin license 102230.

Dr. Eberlein's primary practice is University Health Services - Madison (Highland Ave), at 600 Highland Ave, Madison, WI 53792. The practice phone is (608) 265-1978.

Dr. Eberlein's primary practice is University Health Services - Madison (Highland Ave) in Madison, Wisconsin. Dr. Eberlein is also affiliated with University Hospital. The medical group on file is UW Health. Dmand AI also links Dr. Eberlein to 1 more medical group, named with a free account. Dr. Eberlein's employer is on file too: a school & student health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Eberlein practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Eberlein's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dmand AI has Dr. Eberlein's licenses on file in 3 states: Wisconsin, Iowa and Maryland.

CMS data shows 243 Medicare services from Dr. Eberlein across 3 procedure codes in 2024, for 98 Medicare patients. Medicare paid $24,293 for them.

CMS counts 98 Medicare patients who saw Dr. Eberlein in 2024. The largest group is 65 to 74, with 53 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 16% are also on Medicaid. Their average risk score is 3.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Eberlein's median patient age at 62, with 41% women.

In 2024, Dr. Eberlein wrote 245 Medicare Part D claims for 51 patients. 72% of them were for generic drugs. CMS names the drug for 118 of them, across 6 drugs with 11 or more claims each, at $110,089 in total drug cost. In 2023, CMS named 125 claims across 6 drugs.

Dr. Eberlein accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Eberlein as offering telehealth.

Dmand AI links 115 papers to Dr. Eberlein, published from 2010 to 2025. 2016 was the busiest year, with 7. The most frequent topics are Lung Transplantation, Lung and Lung Neoplasms. Dr. Eberlein has published most often in Eur J Cardiothorac Surg. Dr. Eberlein's most frequent co-authors are Robert Michael Reed, MD, Roy G. Brower, MD and Kalpaj Rajnikant Parekh, MD.

Dmand AI links Dr. Eberlein to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Bronchiolitis Obliterans Syndrome and Organizing Pneumonia.

CMS Open Payments shows 2 general payments to Dr. Eberlein from 2 drug and device companies from 2017 to 2023. Honoraria make up the largest share, 98% of the total. VIDA Diagnostics, Inc. paid the most, $1,000.